These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9333599)

  • 1. [Antithrombotic prevention and therapy in coronary heart disease].
    Bode C; Kohler B; Moser M; Zimmermann R; Strasser RH; Kübler W
    Internist (Berl); 1997 Jul; 38(7):658-66. PubMed ID: 9333599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Harrington RA; Becker RC; Ezekowitz M; Meade TW; O'Connor CM; Vorchheimer DA; Guyatt GH
    Chest; 2004 Sep; 126(3 Suppl):513S-548S. PubMed ID: 15383483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW; Sutton GC
    Chest; 1998 Nov; 114(5 Suppl):611S-633S. PubMed ID: 9822067
    [No Abstract]   [Full Text] [Related]  

  • 6. Problem with aspirin as antithrombotic agent in coronary artery disease.
    Folts JD; Rowe GG; Rao GH
    Lancet; 1988 Apr; 1(8591):937-8. PubMed ID: 2895855
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?
    Spinthakis N; Farag M; Akhtar Z; Gorog DA
    Curr Vasc Pharmacol; 2018; 16(5):427-436. PubMed ID: 29345587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombotic agents and cerebrovascular prevention: what is new?].
    Bogousslavsky J
    Schweiz Med Wochenschr; 1997 Nov; 127(47):1941-4. PubMed ID: 9480533
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.
    Mehran R; Aymong ED; Ashby DT; Fischell T; Whitworth H; Siegel R; Thomas W; Wong SC; Narasimaiah R; Lansky AJ; Leon MB
    Circulation; 2003 Sep; 108(9):1078-83. PubMed ID: 12925457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenia with ticlopidine plus aspirin.
    Neumann FJ; Hall D; Schömig A
    Lancet; 1997 May; 349(9064):1552-3. PubMed ID: 9167482
    [No Abstract]   [Full Text] [Related]  

  • 12. The arterial thrombotic process and emerging drugs for its control.
    Maraganore JM
    Tex Heart Inst J; 1993; 20(1):43-7. PubMed ID: 8508063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antithrombotic therapy in acute myocardial infarction.
    Rihn TL; Vanscoy GJ
    Am J Health Syst Pharm; 2002 Oct; 59(19):1882-5. PubMed ID: 12374078
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary stenting (Cordis) without anticoagulation.
    Park SW; Park SJ; Hong MK; Kim JJ; Cho SY; Jang YS; Kim KB; Kim KS; Oh DJ; Oh BH; Kang JC
    Am J Cardiol; 1997 Apr; 79(7):901-4. PubMed ID: 9104903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A guide to drug use during percutaneous coronary intervention.
    Choo JK; Young JJ; Kereiakes DJ
    Drugs; 2002; 62(18):2589-601. PubMed ID: 12465999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic agents for thrombosis.
    Castaldi PA
    Drugs; 1975; 9(1):1-3. PubMed ID: 1126303
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.
    Mousa SA; DeGrado WF; Mu DX; Kapil RP; Lucchesi BR; Reilly TM
    Circulation; 1996 Feb; 93(3):537-43. PubMed ID: 8565173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.